drugset / Trial / NCT05922384

Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma

NCT05922384

NaSingle-groupOpen-labelTreatment

Summary

This pilot clinical trial studies gene therapy in treating patients with HIV-1 infecetion combined with lymphoma undergoing 7shRNA lentiviral vector transduced CD34+ hematopoietic stem cell transplant. Giving chemotherapy before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. After treatment, CD34+hematopoietic stem cells are mobilized and collected from the patient's peripheral blood. The CD34+stem cells are then isolated and transduced with lenti-7shRNA vector and reinfused to the patient to replace the blood-forming cells that were destroyed by the chemotherapy.

Timeline

Start
2023-07-05
Primary completion
2025-09-10
Completion
2026-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject KL-7SHRNA Unknown
Background Cytarabine Small molecule Intravenous
Background Etoposide Small molecule Intravenous
Background Melphalan Small molecule Intravenous
Background carmustine Small molecule Intravenous